Date Name Title Filing Type Shares Traded Price Total Held
Dec 18, 2012
SVP Clin Devel & Reg Affairs
SVP Clin Devel & Reg Affairs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 $30.63 34,048
Dec 18, 2012
SVP Clin Devel & Reg Affairs
SVP Clin Devel & Reg Affairs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 -- 12,736
Jan 31, 2012
SVP Finance and Admin CFO Trea
SVP Finance and Admin CFO Trea Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 $21.92 114,839
Jan 31, 2012
SVP Finance and Admin CFO Trea
SVP Finance and Admin CFO Trea Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 -- 54,438
Feb 03, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 $7.41 19,127
Feb 03, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 16,000 $15.86 3,127
Feb 03, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 -- --
Mar 21, 2014
Ten Percent Owner
Ten Percent Owner Form 4 Open market or private purchase of non-derivative or derivative security 16,036 $321.23 18,341,127
Jan 06, 2011
SVP F&A, CFO, Treas & Asst Sec
SVP F&A, CFO, Treas & Asst Sec Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,058 $13.00 93,792
Jan 06, 2011
SVP F&A, CFO, Treas & Asst Sec
SVP F&A, CFO, Treas & Asst Sec Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,058 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.